442 related articles for article (PubMed ID: 16855967)
1. Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin.
Algra A; De Schryver EL; van Gijn J; Kappelle LJ; Koudstaal PJ
Cochrane Database Syst Rev; 2006 Jul; (3):CD001342. PubMed ID: 16855967
[TBL] [Abstract][Full Text] [Related]
2. Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin.
Algra A; de Schryver EL; van Gijn J; Kappelle LJ; Koudstaal PJ
Cochrane Database Syst Rev; 2001; (4):CD001342. PubMed ID: 11687110
[TBL] [Abstract][Full Text] [Related]
3. Vitamin K antagonists versus antiplatelet therapy after transient ischaemic attack or minor ischaemic stroke of presumed arterial origin.
De Schryver EL; Algra A; Kappelle LJ; van Gijn J; Koudstaal PJ
Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD001342. PubMed ID: 22972051
[TBL] [Abstract][Full Text] [Related]
4. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
De Schryver EL; Algra A; van Gijn J
Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
[TBL] [Abstract][Full Text] [Related]
5. Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome.
Bala MM; Celinska-Lowenhoff M; Szot W; Padjas A; Kaczmarczyk M; Swierz MJ; Undas A
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD012169. PubMed ID: 33045766
[TBL] [Abstract][Full Text] [Related]
6. Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome.
Bala MM; Celinska-Lowenhoff M; Szot W; Padjas A; Kaczmarczyk M; Swierz MJ; Undas A
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012169. PubMed ID: 28968483
[TBL] [Abstract][Full Text] [Related]
7. Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT): a randomised controlled trial.
; Halkes PH; van Gijn J; Kappelle LJ; Koudstaal PJ; Algra A
Lancet Neurol; 2007 Feb; 6(2):115-24. PubMed ID: 17239798
[TBL] [Abstract][Full Text] [Related]
8. Anticoagulants for preventing recurrence following presumed non-cardioembolic ischaemic stroke or transient ischaemic attack.
Sandercock P; Mielke O; Liu M; Counsell C
Cochrane Database Syst Rev; 2003; (1):CD000248. PubMed ID: 12535394
[TBL] [Abstract][Full Text] [Related]
9. Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks.
Aguilar MI; Hart R; Pearce LA
Cochrane Database Syst Rev; 2007 Jul; (3):CD006186. PubMed ID: 17636831
[TBL] [Abstract][Full Text] [Related]
10. Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm.
Shantsila E; Lip GY
Cochrane Database Syst Rev; 2016 Sep; 9(9):CD003333. PubMed ID: 27629776
[TBL] [Abstract][Full Text] [Related]
11. Anticoagulants for preventing recurrence following presumed non-cardioembolic ischaemic stroke or transient ischaemic attack.
Sandercock PA; Gibson LM; Liu M
Cochrane Database Syst Rev; 2009 Apr; 2009(2):CD000248. PubMed ID: 19370555
[TBL] [Abstract][Full Text] [Related]
12. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
De Schryver EL; Algra A; van Gijn J
Cochrane Database Syst Rev; 2007 Jul; (3):CD001820. PubMed ID: 17636684
[TBL] [Abstract][Full Text] [Related]
13. Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack.
Saxena R; Koudstaal P
Cochrane Database Syst Rev; 2004 Oct; (4):CD000187. PubMed ID: 15494992
[TBL] [Abstract][Full Text] [Related]
14. Multiple versus fewer antiplatelet agents for preventing early recurrence after ischaemic stroke or transient ischaemic attack.
Naqvi IA; Kamal AK; Rehman H
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD009716. PubMed ID: 32813275
[TBL] [Abstract][Full Text] [Related]
15. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
De Schryver EL; Algra A; van Gijn J
Cochrane Database Syst Rev; 2006 Apr; (2):CD001820. PubMed ID: 16625549
[TBL] [Abstract][Full Text] [Related]
16. Antiplatelet and anticoagulation for patients with prosthetic heart valves.
Massel DR; Little SH
Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD003464. PubMed ID: 23839768
[TBL] [Abstract][Full Text] [Related]
17. Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischemic attack or minor stroke of presumed arterial origin.
Algra A; De Schryver EL; van Gijn J; Kappelle LJ; Koudstaal PJ
Stroke; 2003 Jan; 34(1):234-5. PubMed ID: 12511782
[No Abstract] [Full Text] [Related]
18. Combined anticoagulation and antiplatelet therapy for high-risk patients with atrial fibrillation: a systematic review.
Lane DA; Raichand S; Moore D; Connock M; Fry-Smith A; Fitzmaurice DA;
Health Technol Assess; 2013 Jul; 17(30):1-188. PubMed ID: 23880057
[TBL] [Abstract][Full Text] [Related]
19. Anticoagulants versus antiplatelet agents for acute ischaemic stroke.
Berge E; Sandercock P
Cochrane Database Syst Rev; 2002; (4):CD003242. PubMed ID: 12519590
[TBL] [Abstract][Full Text] [Related]
20. Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attacks.
Koudstaal PJ
Cochrane Database Syst Rev; 2000; (2):CD000187. PubMed ID: 10796315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]